KeyVex › Disclosures › Congressional trades

KeyVex publishes these public financial disclosure filings as news, free and without registration, under the news-media provision of 5 U.S.C. § 13107(c). Source documents are linked on every entry.

Mark R Warner (Senate) disclosed 1 transaction

· Congressional trades · U.S. Senate Electronic Financial Disclosure / U.S. House Clerk

2018-10-19 · buyAcumen Pharmaceutical, Inc. Company: Acumen Pharmaceutical, Inc. (Livermore, CA) Description: Drug Discovery — $100,001 - $250,000

The complete record

Every field KeyVex holds for this filing, as its API serves it. Nothing is withheld here that the API sells.

idsenate-7e834dd0-24aa-4f2c-a743-8743ebb07559-1
ownerSelf
partyDemocrat
stateVA
officeWarner, Mark R (Senator)
ptr id7e834dd0-24aa-4f2c-a743-8743ebb07559
ticker—
chambersenate
comment--
amount max250000
amount min100001
asset nameAcumen Pharmaceutical, Inc. Company: Acumen Pharmaceutical, Inc. (Livermore, CA) Description: Drug Discovery
asset typeNon-Public Stock
report urlhttps://efdsearch.senate.gov/search/view/ptr/7e834dd0-24aa-4f2c-a743-8743ebb07559/
bioguide idW000805
data sourceSENATE_EFD_PTR
member lastWarner
member nameMark R Warner
amount range$100,001 - $250,000
member firstMark R
state district—
disclosure date2018-11-08
amendment statusoriginal
transaction date2018-10-19
transaction typebuy
reporting lag days14
transaction natureOPEN_MARKET

Original filing document